Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2004-06-23
2009-12-22
Mosher, Mary E (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S004000, C435S007720, C435S023000, C435S024000
Reexamination Certificate
active
07635557
ABSTRACT:
The present invention is directed towards methods, compositions and kits for testing for a virus in a sample. The methods determine the presence of a viral enzyme by contacting the sample with a peptidal compound capable of being cleaved by the viral enzyme to form peptidal compound fragments. Detection of a peptidal compound fragment confirms the presence of the virus.
REFERENCES:
patent: 4748116 (1988-05-01), Simonsson
patent: 4952493 (1990-08-01), Kettner et al.
patent: 5591591 (1997-01-01), Bronstein
patent: 6037137 (2000-03-01), Komoriya
patent: 6127139 (2000-10-01), Te Kokkele
patent: 6243980 (2001-06-01), Bronstein
patent: 6287767 (2001-09-01), Bronstein
patent: WO 2005/017191 (2005-02-01), None
Chiu RW et al, “Automated extraction protocol for quantification of SARS-Coronavirus RNA in serum: an evaluation study” BMC Infectious Diseases 2006, 6:20-26.
Loens K, et al. “Detection of Rhinoviruses by Tissue Culture and Two Independent Amplification Techniques, Nucleic Acid Sequence-Based Amplification and Reverse Transcription-PCR, in Children with Acute Respiratory Infections during a Winter Season” J Clin Microbiol. Jan. 2006;44(1):166-71.
Cordingley, et al. Cleavage of Small Peptides in Vitro by Human Rhinovirus 14 3C Protease Expressed inEscherichia coli.J. Virol. 1889; 63(12): 5037-5045.
Hata, et al. A simple purification and fluorescent assay method of the poliovirus 3C protease searching for specific inhibitors. Journal of Virological Methods 84 (2000) 117-126.
Manafi, et al. Fluorogenic and Chromogenic Substrates Used in Bacterial Diagnostics. Microbiological Reviews, Sep. 1991, vol. 55, No. 3: p. 335-348.
Wang et al. “Development of A Continous Fluorescence Assay for Rhinovirus 14 3C Protease Using Synthetic Peptides”, Antiviral Chemistry & Chemotherapy, 8(4): 303-310, 1997. p. 303, Abstract, p. 304, 1-h Col., p. 306, r-h Col., Paragraph 2, p. 308, r-h Col., Paragraph 3.
Wang et al. “Development of in Vitro Peptide Substrates for Human Rhinovirus-14 2A Protease”, Archives of Biochemistry and Biophysics, 356(1): 12-18, 1998. p. 12, Abstract, p. 13, r-h Col., Paragraph 3, p. 15, r-h Col., Paragraph 2.
Makinen, K. et al., J. Gen. Virol. vol. 81, pp. 2783-2789 (2000).
Khan, A. R. et al. “Structural aspects of activation pathways of aspartic protease zymogens and viral 3C protease precursors”, Proc. Nat'l. Acad. Sci., vol. 96, No. 20, pp. 10968-10975 (1999).
Rao, M. B. et al., “Molecular and Biotechnological Aspects of Microbial Proteases”, Microbiol. and Mol. Biology Rev., vol. 62, No. 3, p. 597-635 (1998).
Corbalenya, A.E. and Snijder, E.J., “Viral cysteine proteinases, Perspectives in Drug Discovery and Design” 6: pp. 64-86 (1996).
Dougherby, W.G. and Semler, B.L., “Expression of virus-encoded protonases: functional and structural similarities with cellular enzymes”, Microbial. Rev. 57, pp. 781-822 (1993).
John Ziebuhr et al. “Virus-encoded proteinases and proteolytic processing in the Nidovirales”, J. Gen. Vir., vol. 81, pp. 853-879 (2000).
Anand K. et al., Coronavirus Main Protease (3CLpro) Structure: Basis of Design of Anti-SARS Drugs Science, vol. 30, pp. 1763-1767 (2003).
Sosnovtsev, S. V., et al., “Cleavage of the feline calicivirus capsid precursor is mediated by a virus-encoded proteinase”, J. Virol., vol. 72, pp. 3051-3059 (1998).
Wang, W-K “Detection of SARS-associated Coronavirus in Throat Wash and Saliva in Early Diagnosis” Emerg Infect Dis [serial on the Internet] (Jun. 2004). Available from: http://www.cdc.gov
cidod/EID/vol10no7/03-1113.htm.
Wang Q.M. et al., “A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates” Anal. Biochem. vol. 252, pp. 238-245 (1997).
Basak S. et al. “In vitro elucidation of substrate specificity and bioassay of proprotein convertase 4 using intramolecularly quenched fluorogenic peptides” Biochem. J. vol. 380, pp. 505-514 (2004).
Orr D.C. et al. “Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed inE. coli”, J. Gen. Vir. vol. 70, pp. 2931-2942 (1989).
Rota, Paul A et al. “Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome” Science, vol. 300, pp. 1394-1399 (May 30, 2003).
Marra, Marco A. et al., “The Genome Sequence of the SARS-Associated Coronavirus” Science, vol. 300, pp. 1399-1404 (May 30, 2003).
Ksiazek, Thomas G. et al., “A Novel Coronavirus Associated with Severe Respiratory Syndrome” New England Journal of Medicine 348: 20, pp. 1953-1966 (Dec. 2, 2003).
International Search Report for PCT/US2004/019897.
MND Diagnostic Ltd.
Mosher Mary E
Snyder Stuart W
LandOfFree
Enzymatic diagnostic test for SARS and other viral diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enzymatic diagnostic test for SARS and other viral diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzymatic diagnostic test for SARS and other viral diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4148847